Seoul, South Korea

Ildong Pharm Co., Ltd.

USPTO Granted Patents = 9

% Expired Patents = 22.2



Forward Citations = 44

Loading Chart...
Loading Chart...

31 inventors (with patents filed for the assignee):

goldMedal Jae-Hoon Kang (7 out of 16 patents)

silverMedal Seong Beom Kim (2 out of 4 patents)

bronzeMedal Hyei Yoon Jung (2 out of 2 patents)

4.  Seok Woo Yang (2 out of 2 patents)

5.  Hyuk Sang Kwon (2 out of 27 patents)

6.  Yong-Sung Kim (2 out of 11 patents)

7.  Dae-Jung Kang (2 out of 5 patents)

8.  Sun-Young Park (2 out of 31 patents)

9.  Hong-Sub Lee (2 out of 8 patents)

10.  Kyung-Mi An (2 out of 5 patents)

11.  Chang-Hee Hong (2 out of 6 patents)

12.  Jin-Ah Jeong (2 out of 5 patents)

13.  Yoon-Suk Lee (2 out of 7 patents)

14.  Joon-Tae Park (2 out of 3 patents)

15.  Kyung-Sun Kim (2 out of 12 patents)


9 patents:

Company Overview
Ildong Pharm Co., Ltd. is a leading pharmaceutical company in South Korea, specializing in the research, development, and production of innovative healthcare products. With a focus on quality and innovation, Ildong Pharm has established itself as a trusted name in the industry. The company is committed to improving the health and well-being of people around the world through its cutting-edge pharmaceutical solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

9 Patents

#436 in Seoul

#1,189 in South Korea

Seoul, KR
Seoul, South Korea
Forward Citations = 44

31 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ildong Pharm Co., Ltd.. Retrieved from https://idiyas.com/company/ildong-pharm-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…